Eligibility Stage II Prostate Carcinoma NCT01618838

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically confirmed adenocarcinoma of the prostate (biopsy within one year of enrollment)
Descripción

Prostatic Neoplasms adenocarcinoma

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0033578
UMLS CUI [1,2]
C0001418
signed study-specific consent
Descripción

informed consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
psa within 60 days of registration
Descripción

Prostate-Specific Antigen

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0138741
baseline aua/ ipss score of < 20
Descripción

American Urological Association Symptom Score

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3831551
candidate for screening colonoscopy
Descripción

colonoscopy; screening for cancer

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0009378
UMLS CUI [2]
C0199230
pretreatment colonoscopy/lower endoscopy done
Descripción

pretreatment colonoscopy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3539076
UMLS CUI [1,2]
C0009378
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior pelvic radiotherapy
Descripción

pelvic radiotherapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0436276
prior radical prostate surgery
Descripción

ID.8

Tipo de datos

boolean

recent (within 5 years) or concurrent cancers other than non-melanoma skin cancer
Descripción

cancers concurrent

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0006826
UMLS CUI [1,2]
C0205420
implanted hardware adjacent to the prostate that would prohibit appropriate treatment planning and/or treatment delivery
Descripción

implantations

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021107
inflammatory bowel disease
Descripción

inflammatory bowel disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021390

Similar models

Eligibility Stage II Prostate Carcinoma NCT01618838

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Prostatic Neoplasms adenocarcinoma
Item
histologically confirmed adenocarcinoma of the prostate (biopsy within one year of enrollment)
boolean
C0033578 (UMLS CUI [1,1])
C0001418 (UMLS CUI [1,2])
informed consent
Item
signed study-specific consent
boolean
C0021430 (UMLS CUI [1])
Prostate-Specific Antigen
Item
psa within 60 days of registration
boolean
C0138741 (UMLS CUI [1])
American Urological Association Symptom Score
Item
baseline aua/ ipss score of < 20
boolean
C3831551 (UMLS CUI [1])
colonoscopy; screening for cancer
Item
candidate for screening colonoscopy
boolean
C0009378 (UMLS CUI [1])
C0199230 (UMLS CUI [2])
pretreatment colonoscopy
Item
pretreatment colonoscopy/lower endoscopy done
boolean
C3539076 (UMLS CUI [1,1])
C0009378 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
pelvic radiotherapy
Item
prior pelvic radiotherapy
boolean
C0436276 (UMLS CUI [1])
ID.8
Item
prior radical prostate surgery
boolean
cancers concurrent
Item
recent (within 5 years) or concurrent cancers other than non-melanoma skin cancer
boolean
C0006826 (UMLS CUI [1,1])
C0205420 (UMLS CUI [1,2])
implantations
Item
implanted hardware adjacent to the prostate that would prohibit appropriate treatment planning and/or treatment delivery
boolean
C0021107 (UMLS CUI [1])
inflammatory bowel disease
Item
inflammatory bowel disease
boolean
C0021390 (UMLS CUI [1])